ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 110.00
-0.40 (-0.36%)
Feb 19, 2026, 5:36 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €8.59 billion as of February 19, 2026. Its market cap has increased by 2,038.82% in one year.
Market Cap
8.59B
Enterprise Value
8.08B
Revenue
5.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€110.00
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 8.59B, an increase of 4,151.10%. That is a compound annual growth rate of 42.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 8.59B | -8.31% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.08B |
| DBV Technologies | 1.02B |
| Inventiva | 1.00B |
| MedinCell | 812.34M |
| Valneva SE | 805.17M |
| Genfit | 399.61M |
| Cellectis | 238.31M |
| Transgene | 230.01M |